BRAF and ameloblastoma: While the BRAF p.V600E mutation emerged as a molecular signature for ameloblastomas and has also been shown to be frequent in other tumors with ameloblastic differentiation, KRAS codon 12 mutations seem to be a marker of adenomatoid odontogenic tumors [11, 12, 74].